
The zzso and death rate of prostate cancer is increasing zzso In addition, the low sensitivity of prostate cancer to chemotherapy makes it difficult to treat this zzso The zzso zzso zzso plays an important role in cell cycle progression and zzso zzso resulting in prostate zzso zzso zzso zzso has been expected to be an attractive target for developing new zzso zzso However, no small compounds targeting zzso have progressed to clinical use because of their lack of zzso Here, we have reported a new zzso zzso zzso zzso zzso that could interfere with the binding of zzso to its zzso and act as an zzso zzso The zzso could bind to zzso and inhibit zzso of zzso zzso and Bad by zzso Treatment of prostate cancer with the zzso zzso zzso arrest and subsequently zzso in zzso However, the zzso showed almost no growth zzso or zzso effects in normal zzso The zzso could inhibit tumor growth in in zzso prostate cancer zzso zzso Moreover, the zzso treatment could overcome resistance to zzso one of the first line zzso agents for prostate cancer, and a combination of the zzso with zzso zzso inhibited prostate cancer growth in zzso These results indicate that a zzso zzso zzso zzso could be developed as an zzso drug against prostate zzso 

